Presentation TCT 2025 TCT 39: Hypo-Attenuated Leaflet Thickening After Transcatheter Tricuspid Valve Replacement: A Proposed Severity Scale and Clinical Correlates Presenter: Hannah Kempton October 27, 2025
Presentation TCT 2025 TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients Presenter: Noah Tregobov October 27, 2025
Presentation TCT 2025 TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method Presenter: Dejing Feng October 25, 2025
Presentation TCT 2025 TCT 1: One-Year Outcomes of the RESILIA Balloon-Expandable Transcatheter Valve: Survival, Hemodynamics, and Hypoattenuated Leaflet Thickening Presenter: Kazuki Suruga October 25, 2025
News Daily News ‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use Yael L. Maxwell June 18, 2025
News Conference News EuroPCR 2025 Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI Michael O'Riordan May 23, 2025